Philip Stevens

Philip Stevens is an accomplished professional with extensive experience in leadership and research within the biotechnology and bioengineering sectors. Currently serving as CEO of Noscendo GmbH since December 2016, Philip has demonstrated expertise in driving company growth and innovation. Prior roles include Research Scientist at Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB from 2016 to 2017, and Research Scientist at Universität Stuttgart from 2014 to 2017. Philip also pursued a PhD at the University of Vienna during this period, enriching academic and practical knowledge in relevant fields.